13.07.2022 | Brief Report
Dual emission laser treatment and argon plasma coagulation in small bowel vascular lesion ablation: a pilot study
Erschienen in: Lasers in Medical Science | Ausgabe 9/2022
Einloggen, um Zugang zu erhaltenExcerpt
The 1.9/1.5 μm dual emission endoscopic laser treatment (1.9/1.5 μm DEELT) is a recent endoscopic tool that has been demonstrated as safe and effective in the treatment of vascular gastrointestinal lesions [1‐4]. The intrinsic flexibility and manoeuvrability of the laser fibre, together with a precise photo-coagulative effect, are theoretically ideal characteristics for enteroscopic procedures. To date, there are no studies assessing the safety and efficacy of the 1.9/1.5 μm DEELT in the treatment of small bowel vascular lesions [5]. We attempted to provide answers to these open questions in a retrospective study comparing the 1.9/1.5 μm DEELT with a historical, random forest–matched cohort of argon plasma coagulation (APC)–treated small bowel enteroscopic procedures. …Anzeige